-
Mashup Score: 0FDA grants breakthrough device designation to blood-based Alzheimer’s biomarker assay - 9 day(s) ago
The FDA has granted breakthrough device designation to a blood-based biomarker test to more quickly detect amyloid presence in individuals with suspected Alzheimer’s disease, according to the manufacturer.In a press release, Roche said its Elecsys phospho-tau 217 assay, which is being developed in collaboration with Eli Lilly & Co., is intended to be an in vitro diagnostic immunoassay
Source: www.healio.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Round Table Discussion on Aerolase Energy-Based Devices For Comprehensive Skincare Treatments for Fitzpatrick Skin Types I-VI. - 18 day(s) ago
At the core, our devices focus on dermatologic conditions, requiring more effective therapeutic options and more acceptable to patient standards and levels of safety. Aerolase develops scalable, leading-edge devices for forward-thinking medical professionals who want to deliver top-of-the-line therapies, immeasurable patient experiences, and incredible patient results for all things skin-related. We develop lasers with everything you need to take your work to the next level power, capability, and
Source: www.dermatologytimes.comCategories: General Medicine News, DermatologyTweet
-
Mashup Score: 02024 Europe Symposium | AECOS - 24 day(s) ago
The American-European Congress of Ophthalmic Surgery welcomes you to the annual AECOS Europe Symposium. Join us for an Opening Reception at the Hotel Don Giovanni l on Thursday, June 6 from 18:30…
Source: aecosurgery.orgCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 1XDEMVY Experts: Real-World Patient and MD Perspectives - 30 day(s) ago
Featuring six intricate case presentations and engaging seven expert panelists in invigorating discussions, this live, interactive, virtual event will act as a practical and pivotal guide for surgeons. We aim to educate ophthalmologists on how to navigate unexpected complications in a calm and calculated fashion, turning what might seem overwhelming into something that looks routine the next day.
Source: events.avenue.liveCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 78Expand and Elevate with Alcon PCIOLs - 1 month(s) ago
Featuring six intricate case presentations and engaging seven expert panelists in invigorating discussions, this live, interactive, virtual event will act as a practical and pivotal guide for surgeons. We aim to educate ophthalmologists on how to navigate unexpected complications in a calm and calculated fashion, turning what might seem overwhelming into something that looks routine the next day.
Source: events.avenue.liveCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 78Expand and Elevate with Alcon PCIOLs - 1 month(s) ago
Featuring six intricate case presentations and engaging seven expert panelists in invigorating discussions, this live, interactive, virtual event will act as a practical and pivotal guide for surgeons. We aim to educate ophthalmologists on how to navigate unexpected complications in a calm and calculated fashion, turning what might seem overwhelming into something that looks routine the next day.
Source: events.avenue.liveCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 5IL-31: An important neuroimmune cytokine in prurigo nodularis and atopic dermatitis - 1 month(s) ago
This article is authored by Dr. Baldo Scassellati Sforzolini, M.D., Ph.D., MBA, Global Head of R&D, Galderma and Dr. Christophe Piketty, M.D., Ph.D., Global Senior Program Head at Galderma. IL-31 is a neuroimmune cytokine that drives the most burdensome symptom in prurigo nodularis and atopic dermatitis, namely itch, and is also involved in skin inflammation and keratinocyte abnormalities.
Source: www.dermatologytimes.comCategories: General Medicine News, DermatologyTweet
-
Mashup Score: 1Round Table Discussion on Aerolase Energy-Based Devices For Comprehensive Skincare Treatments for Fitzpatrick Skin Types I-VI. - 1 month(s) ago
At the core, our devices focus on dermatologic conditions, requiring more effective therapeutic options and more acceptable to patient standards and levels of safety. Aerolase develops scalable, leading-edge devices for forward-thinking medical professionals who want to deliver top-of-the-line therapies, immeasurable patient experiences, and incredible patient results for all things skin-related. We develop lasers with everything you need to take your work to the next level power, capability, and
Source: www.dermatologytimes.comCategories: General Medicine News, DermatologyTweet
-
Mashup Score: 0XDEMVY Experts: Real-World Patient and MD Perspectives - 2 month(s) ago
Featuring six intricate case presentations and engaging seven expert panelists in invigorating discussions, this live, interactive, virtual event will act as a practical and pivotal guide for surgeons. We aim to educate ophthalmologists on how to navigate unexpected complications in a calm and calculated fashion, turning what might seem overwhelming into something that looks routine the next day.
Source: events.avenue.liveCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 5IL-31: An important neuroimmune cytokine in prurigo nodularis and atopic dermatitis - 2 month(s) ago
This article is authored by Dr. Baldo Scassellati Sforzolini, M.D., Ph.D., MBA, Global Head of R&D, Galderma and Dr. Christophe Piketty, M.D., Ph.D., Global Senior Program Head at Galderma. IL-31 is a neuroimmune cytokine that drives the most burdensome symptom in prurigo nodularis and atopic dermatitis, namely itch, and is also involved in skin inflammation and keratinocyte abnormalities.
Source: www.dermatologytimes.comCategories: General Medicine News, DermatologyTweet
On the heels of Quanterix, @Roche & @EliLillyandCo announced a partnership to develop a p-tau217 blood-based biomarker assay for detection of #AD. The @US_FDA granted breakthrough designation for the project: https://t.co/U7kaLvr5jx